Drs. David Ilson, Sumanta (Monty) Pal, and Tian Zhang discuss new research presented at the 2022 ESMO Congress, including studies about treating liver, colorectal, stomach, kidney, bladder, and prostate cancers.
2022 ASCO Annual Meeting: Advances in Treating Breast Cancer, Colorectal Cancer, Ewing Sarcoma, and Multiple Myeloma
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma.
2022 ASCO Annual Meeting: Targeted Therapy for Advanced HR-Positive, HER2-Negative Breast Cancer and Using Liquid Biopsy to Guide Treatment for Stage II Colon Cancer
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer.
At-home DNA tests have become increasingly popular in recent years. But are they actually helpful for detecting cancer risk? In this post, learn about at-home DNA tests for cancer risk and why it’s always best to get genetic screening done through your health care provider.
Colorectal cancer survivor Danielle Ripley-Burgess shares what it was like being diagnosed with colorectal cancer twice, at ages 17 and 25, and how she navigated coping with her diagnosis as a teen and young adult.
2021 ASCO Annual Meeting Research Round Up: Advances in Treating Brain Tumors, Esophageal Cancer, and Colorectal Cancer
In this podcast, Cancer.Net Associate Editors discuss new research presented at the 2021 ASCO Annual Meeting on brain tumors, esophageal cancer, and colorectal cancer.
“No Person With Cancer or Survivor Should Ever Feel Alone”: A Patient Advocate’s ASCO Annual Meeting Story
Colon cancer survivor Robert Greene shares how his diagnosis led him to patient advocacy and how attending the ASCO Annual Meeting has helped him feel more involved with the cancer community.
In this article from "The ASCO Post," colorectal cancer survivor Scott Wilson discusses how his diagnosis led him on a path to patient advocacy to raise awareness of colorectal cancer.
ASCO’s 2021 Advance of the Year highlights how progress in the treatment of gastrointestinal (GI) cancers is driven by molecular testing of tumors.
In this post, Dan Shockley discusses how his experience in the United States Navy helped shape his mindset and prepared him to keep a positive outlook throughout the diagnosis and treatment of his hereditary colon cancer condition.